Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis: An update and proposals for guidelines

References

• O'Dell JR. Methotrexate use in rheumatoid arthritis. Rheum Dis Clin North Am 1997;23:779–96.
   PubMed Web of Science ®Google Scholar
• Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheum-atoid arthritis: a metaanalysis of published clinical trials. Arthritis Rheum 1992;35:1117–25.
   Google Scholar
• Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C. Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology 2000;39:975–81.
   PubMed Web of Science ®Google Scholar
• Alarcon GS, Lopez-Mendez A, Walter J, Boerbooms AMT, Russel AS, Furst DE et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate dis-ease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1868–73.
   PubMed Web of Science ®Google Scholar
• O'Dell JR. Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis. Rheum Dis Clin North Am 1998;24:465–77.
   PubMedGoogle Scholar
• Kremer JM. Methotrexate and emerging therapies. Rheum Dis Clin North Am 1998;24:651–8.
   PubMedGoogle Scholar
• O'Dell JR, Scott DL. Rheumatoid arthritis: new developments in the use of existing therapies. Rheumatology 1999:38 Suppl 2:24–6.
   PubMedGoogle Scholar
• Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 1989;16:313–20.
   Google Scholar
• Alarcen GS, Tracy IC, Blackburn, WD. Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989;32: 671–6.
   Google Scholar
• Schnabel A, Gross WL. Low-dose methotrexate in rheumatic diseases: efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 1994;23:310–27.
   PubMed Web of Science ®Google Scholar
• Kremer JM, Phelps CT. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: update after a mean of 90 months. Arthritis Rheum 1992;35:138–45.
   PubMed Web of Science ®Google Scholar
• Kremer JM. Methotrexate update. Scand J Rheumatol 1996;25:341–4.
   PubMed Web of Science ®Google Scholar
• Morgan SL, Baggott JE, Altz-Smith M. Folate status of rheumatoid arthritis patients receiving long-term, low dose methotrexate therapy. Arthritis Rheum 1987;30:1348–56.
   Google Scholar
• Andersen LS, Hansen EL, Knudsen JB, Wester JU, Hansen GVO, Hansen TM. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arth-ritis: relation to withdrawal and side effects. J Rheumatol 1997;24:830–7.
   PubMedGoogle Scholar
• Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H, et al. Folic acid and cyancobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol 1995;13:459–63.
   Google Scholar
• Dijkmans BAC. Folate supplementation and methotrexate. Br J Rheumatol 1995;34:1172–4.
   PubMedGoogle Scholar
• Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis: an update. Drugs 1994;47:25–50.
   PubMed Web of Science ®Google Scholar
• Van Ede AE, Laan RFJM, Blom HJ, De Abreu RA, Van de Putte LBA. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum 1998;27:277–92.
   Google Scholar
• Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum 1990;20:190–200.
   Google Scholar
• Cronstein BN. Methotrexate and its mechanism of action. Arthritis Rheum 1996;39:1951–60.
   PubMed Web of Science ®Google Scholar
• Allen RH. Megaloblastic anemias. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. Philadelphia, Saunders, 1996:843–51.
   Google Scholar
• Hillson JL, Furst DE. Pharmacology and pharmacokinetics of methotrexate in rheumatic disease: practical issues in treat-ment and design. Rheum Dis Clin North Am 1997;23:757–78.
   PubMed Web of Science ®Google Scholar
• Van Ede AE, Laan R, Huizinga T, Haagsma C, Giesendorf B, Blom H et al. The C677T mutation in the MTHFR-gene: association with efficacy and toxicity of methotrexate, with or without folate supplementation, in the treatment of rheuma-toid arthritis patients (abstract). Arthritis Rheum 1999;42 Suppl: S380.
   Google Scholar
• Kremer JM, Mroczkowski P, Kelly S, Hausner D, Nami A, Hall MJ et al. Betaine supplementation in patients with rheumatoid arthritis (RA) is associated with a decrease in homocysteine and increases in methionine, IL-2 and TN Ta: clues to how MTX acts (abstract). Arthritis Rheum 1999;42 Suppl: S380.
   Google Scholar
• Kremer JM, Galivan J, Streckfuss A, Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and forma-tion of polyglutamates. Arthritis Rheum 1986;29:832–5.
   PubMed Web of Science ®Google Scholar
• Joyce DA, Will RK, Hoffman DM, Laing B, Blackbourn SJ. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 1991;50:913–4.
   Google Scholar
• Tishler M, Caspi D, Fishel B, Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheuma-toid arthritis patients. Arthritis Rheum 1988;31:906–8.
   PubMed Web of Science ®Google Scholar
• Shiroky JB, Neville C, Esdaile JM, Choquette D, Zummer M, Hazeltine M et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis: results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1993;36:795–803.
   PubMed Web of Science ®Google Scholar
• Hanrahan PS, Russell AS. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J. Rheumatol 1988;15:1078–80.
   PubMedGoogle Scholar
• Buckley LM, Vacek PM, Cooper SM. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. J Rheumatol 1990;17:1158–61.
   Google Scholar
• Weinblatt ME, Maier AL, Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheuma-toid arthritis: an 8 week randomized placebo controlled trial. J. Rheumatol 1993;20: 950–2.
   Google Scholar
• Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990;33:9–18.
   PubMed Web of Science ®Google Scholar
• Stewart KA, Mackenzie AH, Clough JD, Wilke WS. Folate supplementation in methotrexate-treated rheumatoid arthritis patients. Semin Arthritis Rheum 1991;20:332–8.
   PubMed Web of Science ®Google Scholar
• Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY et al. Supplementation with folic acid during metho-trexate therapy for rheumatoid arthritis: a double-blind, pla-cebo-controlled trial. Ann Intern Med 1994;121:833–41.
   PubMed Web of Science ®Google Scholar
• Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. J Am Acad Dermatol 1993;28:466–9.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Uehara R, Tajima C, Noguchi A, Ide M, Ichikawa Y et al. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate: risk factors and response to folic acid. Scand J Rheumatol 1999;28:273–81.
   PubMed Web of Science ®Google Scholar
• Van Ede AV, Laan R, Rood M, Huizinga T, Van de Laar M, Van Denderen J et al. Effect of folic and folinic acid suppletion on toxicity and efficacy of methotrexate in rheumatoid arthritis: a randomized, double-blind, 48 week, clinical trial (abstract). Arthritis Rheum 1999;42 Suppl: S380.
   Google Scholar
• Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials. J Rheumatol 1998;25:36–43.
   Google Scholar
• Shiroky JB. The use of folates concomitantly with low-dose pulse methotrexate. Rheum Dis Clin North Am 1997;23:969–80.
   PubMedGoogle Scholar
• McKendry RJR. The remarkable spectrum of methotrexate toxicities. Rheum Dis Clin North Am 1997;23:939–54.
   PubMedGoogle Scholar
• Richard S, Guerret S, Gerard F, Tebib JG, Vignon E. Hepatic fibrosis in rheumatoid arthritis patients treated with metho-trexate: application of a new semi-quantitative scoring system. Rheumatology 2000;39:50–4.
   Google Scholar
• Weinblatt ME, Fraser P. Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy. Arthritis Rheum 1989;32:1592–6.
   PubMed Web of Science ®Google Scholar
• Bessman JD, Gilmer PR, Gardner FH. Improved classifica-tion of anemias by MCV and RDW. Am J Clin Pathol 1983;80:322–6.
   PubMedGoogle Scholar
• Bergin JJ. Evaluation of anemia: getting the most out of the MCV, RDW, and other tests. Postgrad Med 1985;77:253–69.
   PubMed Web of Science ®Google Scholar
• Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J. Clin Nutr 1989;50:353–8.
   PubMed Web of Science ®Google Scholar
• Jobanputra P, Hunter M, Clark D, Lambert CM, Hurst NP. An audit of methotrexate and folic acid for rheumatoid arthritis: experience from a teaching centre. Br J Rheumatol 1995;34:971–5.
   Google Scholar
• Combe B, Kinowski JM, Pouly B, Sany J, Bressolle F. Folic acid alters methotrexate (MTX) disposition in rheumatoid (RA) patients (abstract). Arthritis Rheum 1999;42 Suppl: S76.
   Google Scholar
• Bressolle F, Kinowski JM, Morel J, Pouly B, Sany J, Combe B. Folic acid alters methotextrate availability in patients with rheumatoid arthritis. J Rheumatol 2000;27:2110–4.
   PubMed Web of Science ®Google Scholar